Ildong Holdings Co., Ltd. (000230.KS)
KRW 6600.0
(-5.44%)
KRW 6600.0
(-5.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 876.99 Billion KRW | 1.67% |
| 2022 | 862.55 Billion KRW | -6.32% |
| 2021 | 920.76 Billion KRW | 15.18% |
| 2020 | 799.39 Billion KRW | -0.77% |
| 2019 | 805.62 Billion KRW | 203.47% |
| 2018 | 265.46 Billion KRW | -3.41% |
| 2017 | 274.83 Billion KRW | 34.67% |
| 2016 | 204.08 Billion KRW | -71.08% |
| 2015 | 705.63 Billion KRW | 13.75% |
| 2014 | 620.34 Billion KRW | -1.25% |
| 2013 | 628.21 Billion KRW | 15.97% |
| 2012 | 541.71 Billion KRW | 5.88% |
| 2011 | 511.65 Billion KRW | -3.69% |
| 2010 | 531.23 Billion KRW | 7.2% |
| 2009 | 495.53 Billion KRW | 22.42% |
| 2008 | 404.78 Billion KRW | 20.46% |
| 2007 | 336.03 Billion KRW | 18.42% |
| 2006 | 283.77 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 854.92 Billion KRW | -2.52% |
| 2024 Q2 | 861.23 Billion KRW | 0.74% |
| 2023 Q4 | 876.99 Billion KRW | 13.89% |
| 2023 Q1 | 838.01 Billion KRW | -2.85% |
| 2023 Q2 | 829.02 Billion KRW | -1.07% |
| 2023 FY | 876.99 Billion KRW | 1.67% |
| 2023 Q3 | 770.04 Billion KRW | -7.11% |
| 2022 Q3 | 905.88 Billion KRW | -2.22% |
| 2022 Q1 | 921.09 Billion KRW | 0.04% |
| 2022 FY | 862.55 Billion KRW | -6.32% |
| 2022 Q4 | 862.55 Billion KRW | -4.78% |
| 2022 Q2 | 926.45 Billion KRW | 0.58% |
| 2021 Q1 | 875.98 Billion KRW | 9.58% |
| 2021 FY | 920.76 Billion KRW | 15.18% |
| 2021 Q4 | 920.76 Billion KRW | 0.23% |
| 2021 Q3 | 918.62 Billion KRW | 2.05% |
| 2021 Q2 | 900.12 Billion KRW | 2.76% |
| 2020 Q2 | 792.52 Billion KRW | -1.73% |
| 2020 Q1 | 806.46 Billion KRW | 0.1% |
| 2020 FY | 799.39 Billion KRW | -0.77% |
| 2020 Q3 | 789.28 Billion KRW | -0.41% |
| 2020 Q4 | 799.39 Billion KRW | 1.28% |
| 2019 FY | 805.62 Billion KRW | 203.47% |
| 2019 Q4 | 805.62 Billion KRW | -4.44% |
| 2019 Q2 | 282.52 Billion KRW | 0.74% |
| 2019 Q1 | 280.45 Billion KRW | 5.64% |
| 2019 Q3 | 843.06 Billion KRW | 198.4% |
| 2018 Q2 | 273.38 Billion KRW | -0.5% |
| 2018 Q1 | 274.75 Billion KRW | -0.03% |
| 2018 FY | 265.46 Billion KRW | -3.41% |
| 2018 Q4 | 265.46 Billion KRW | -3.66% |
| 2018 Q3 | 275.55 Billion KRW | 0.8% |
| 2017 Q4 | 274.83 Billion KRW | 0.56% |
| 2017 FY | 274.83 Billion KRW | 34.67% |
| 2017 Q1 | 255.65 Billion KRW | 25.27% |
| 2017 Q2 | 272.86 Billion KRW | 6.73% |
| 2017 Q3 | 273.32 Billion KRW | 0.17% |
| 2016 Q1 | 714.56 Billion KRW | 1.26% |
| 2016 Q4 | 204.08 Billion KRW | -3.05% |
| 2016 Q3 | 210.51 Billion KRW | -71.04% |
| 2016 Q2 | 726.85 Billion KRW | 1.72% |
| 2016 FY | 204.08 Billion KRW | -71.08% |
| 2015 Q4 | 705.63 Billion KRW | 9.11% |
| 2015 FY | 705.63 Billion KRW | 13.75% |
| 2015 Q3 | 646.71 Billion KRW | 1.89% |
| 2015 Q2 | 634.68 Billion KRW | 1.8% |
| 2015 Q1 | 623.45 Billion KRW | 0.5% |
| 2014 FY | 620.34 Billion KRW | -1.25% |
| 2014 Q4 | 620.34 Billion KRW | 0.4% |
| 2014 Q3 | 617.89 Billion KRW | 1.26% |
| 2014 Q2 | 610.2 Billion KRW | 1.21% |
| 2014 Q1 | 602.89 Billion KRW | -4.03% |
| 2013 Q4 | 628.21 Billion KRW | 2.64% |
| 2013 FY | 628.21 Billion KRW | 15.97% |
| 2013 Q3 | 612.05 Billion KRW | -0.24% |
| 2013 Q1 | 557.34 Billion KRW | 2.89% |
| 2013 Q2 | 613.53 Billion KRW | 10.08% |
| 2012 FY | 541.71 Billion KRW | 5.88% |
| 2012 Q4 | 541.71 Billion KRW | 0.0% |
| 2012 Q1 | 485.09 Billion KRW | 0.0% |
| 2011 Q1 | 480.07 Billion KRW | 0.0% |
| 2011 Q2 | 486.65 Billion KRW | 1.37% |
| 2011 Q3 | 491.12 Billion KRW | 0.92% |
| 2011 FY | 511.65 Billion KRW | -3.69% |
| 2010 Q2 | 435.87 Billion KRW | 0.0% |
| 2010 Q3 | 430.25 Billion KRW | -1.29% |
| 2010 FY | 531.23 Billion KRW | 7.2% |
| 2009 Q4 | 379.43 Billion KRW | 5.28% |
| 2009 Q3 | 360.39 Billion KRW | 6.77% |
| 2009 FY | 495.53 Billion KRW | 22.42% |
| 2009 Q2 | 337.53 Billion KRW | 0.0% |
| 2008 Q4 | 306.59 Billion KRW | 3.44% |
| 2008 Q2 | 284.06 Billion KRW | 0.0% |
| 2008 Q3 | 296.4 Billion KRW | 4.35% |
| 2008 FY | 404.78 Billion KRW | 20.46% |
| 2007 FY | 336.03 Billion KRW | 18.42% |
| 2007 Q2 | 251.21 Billion KRW | 0.0% |
| 2007 Q4 | 267.04 Billion KRW | 3.86% |
| 2007 Q3 | 257.11 Billion KRW | 2.35% |
| 2006 FY | 283.77 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -342.452% |
| Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | 55.189% |
| HANDOK Inc. | 790.33 Billion KRW | -10.965% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -414.007% |
| Yuhan Corporation | 2814.07 Billion KRW | 68.835% |
| Dong-A ST Co., Ltd. | 1315.21 Billion KRW | 33.319% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -838.177% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | 55.073% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -265.802% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -87.032% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -662.785% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -270.748% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -151.732% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -342.452% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -109.213% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -75.479% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -48.796% |
| JW Holdings Corporation | 1176.26 Billion KRW | 25.442% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -43.474% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | 37.466% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -35.961% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -150.511% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -469.328% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -136.592% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -79.961% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -342.452% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | 18.651% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | 50.461% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -35.961% |
| Yuhan Corporation | 2814.07 Billion KRW | 68.835% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | 0.341% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -287.024% |
| Suheung Co., Ltd. | 993.73 Billion KRW | 11.747% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -35.961% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -108.858% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -87.049% |
| CKD Bio Corp. | 293.78 Billion KRW | -198.517% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -72.638% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -55.229% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -118.579% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -150.511% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | 39.767% |
| Boryung Corporation | 922.36 Billion KRW | 4.918% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -98.209% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -87.032% |
| JW Lifescience Corporation | 255.83 Billion KRW | -242.797% |